Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction

Author:

Dhaliwal Inderdeep1,Mahdavian Masoud2,Asghari Shabnam3,Chun To Wong Benson4,Labelle Rosalie5,Amjadi Kayvan6ORCID

Affiliation:

1. Schulich School of Medicine, Western University, Victoria Hospital, London Health Sciences Centre, London, ON, Canada

2. Division of Respirology, Faculty of Medicine, Memorial University of Newfoundland (MUN), St. John’s, NL, Canada

3. Discipline of Family Medicine, Health Sciences Centre, Memorial University of Newfoundland (MUN), St. John’s, NL, Canada

4. Division of Respirology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada

5. Department of Medicine, Division of Interventional Pulmonology, The Ottawa Hospital, Ottawa, ON, Canada

6. Division of Interventional Pulmonology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada

Abstract

Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system.Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses.Results. 50 patients with MPE with a mean age of64.5±1.9, BDI of2.8±0.9, and ECOG score of3.0±0.7were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18,p<0.001), QLQ-C30 dyspnea (−39,p<0.00001), and LC13 dyspnea (−11,p<0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use.Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE.

Funder

Department of Medicine’s Patient Quality and Safety Committee Research Award

Publisher

Hindawi Limited

Subject

Pulmonary and Respiratory Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3